#United States #The Woodlands #Cell Therapy #Cellipont #GMP Batch

Celebrating a Milestone: Cellipont Bioservices' 100th GMP Batch Release

In a remarkable feat, Cellipont Bioservices has announced the successful release of its 100th Good Manufacturing Practice (GMP) batch at their manufacturing facility located in The Woodlands, Texas. This achievement is particularly noteworthy as it follows the commencement of GMP manufacturing operations just a year prior, in June 2025.

With the increasing demand for innovative cell therapies, this significant milestone underscores the robust operational capabilities that Cellipont has developed. The company has managed to deliver this volume of GMP batches in a remarkably short time frame, showcasing not only their manufacturing proficiency but also the depth of expertise among their dedicated teams.

Darren Head, CEO of Cellipont Bioservices, expressed immense pride in his team’s accomplishments. He remarked, “Reaching our 100th GMP batch release approximately one year after beginning manufacturing operations is an impressive achievement and a testament to the expertise, collaboration, and commitment our employees bring to every client program.” This strong sentiment reflects the collective effort from various departments within the organization including Manufacturing, Quality Assurance, Supply Chain Management, Manufacturing Science and Technology, Facilities Management, and Validation, all contributing to maintaining stringent quality standards while adhering to critical client timelines.

Every batch represents a significant trust placed in Cellipont by their clients and showcases a shared responsibility towards advancing potentially transformative cell therapies. Head continued, “This milestone belongs to our entire team, and we are proud to celebrate what they have achieved while continuing to build for the future.”

Looking ahead, Cellipont is poised to further expand its capabilities and operational experience, supporting cell therapy developers throughout the entire process, from initial developmental phases to clinical and large-scale commercial manufacturing.

About Cellipont Bioservices

Cellipont Bioservices is a premier Contract Development and Manufacturing Organization (CDMO) specializing in cell therapies. The company employs a team of industry-leading experts dedicated to facilitating advancements in cell therapy development and manufacturing. Their Texas-based facility is purpose-built, integrating state-of-the-art technology aligned with their unwavering commitment to quality. This ensures they not only meet but strive to exceed the expectations of their clients and the communities they serve. For more information about Cellipont and their services, visit www.cellipont.com and follow them on LinkedIn.